Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register

OBJECTIVES: To describe the baseline characteristics of SLE patients requiring biologic therapy in the UK and to explore short term efficacy and infection rates associated with rituximab (RTX) use. METHODS: Patients commencing biologic therapy for refractory SLE and who consented to join BILAG-BR we...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Rheumatology (Oxford)
Glavni autori: McCarthy, Eoghan M, Sutton, Emily, Nesbit, Stephanie, White, James, Parker, Ben, Jayne, David, Griffiths, Bridget, Isenberg, David A, Rahman, Anisur, Gordon, Caroline, D'Cruz, David P, Rhodes, Benjamin, Lanyon, Peter, Vital, Edward M, Yee, Chee-Seng, Edwards, Christopher J, Teh, Lee-Suan, Akil, Mohammed, McHugh, Neil J, Zoma, Asad, Bruce, Ian N
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Clinical Science
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5850287/
https://ncbi.nlm.nih.gov/pubmed/29216396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kex395
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items